Active Ingredient(s): Telotristat Ethyl
FDA Approved: * February 28, 2017
Category: Gastrointestinal

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Xermelo Overview

Telotristat ethyl (USAN, brand name Xermelo) is a prodrug of telotristat, which is an inhibitor of tryptophan hydroxylase. It is formulated as telotristat etiprate — a hippurate salt of telotristat ethyl.[1] On February 28, 2017, the U.S. Food and Drug Administration (FDA) approved telotristat ethyl in combination with somatostatin analog (SSA) therapy for the treatment of adults with diarrhea associated with carcinoid syndrome that SSA therapy alone has inadequately con...

Read more Xermelo Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Telotristat_ethyl

Recent Xermelo Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Telotristat Ethyl
  • Tablet: 250mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Xermelo: (2 results)

Sorted by National Drug Code
  • 70183-125 Xermelo 250 mg Oral Tablet by Lexicon Pharmaceuticals, Inc.
  • 70720-125 Xermelo 250 mg Oral Tablet by Tersera Therapeutics LLC

Other drugs which contain Telotristat Ethyl or a similar ingredient: (1 result)

Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 11 May 2021.

We are committed to your privacy.

Copyright © 2005-2021 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA